The rate of PD-L1 positivity varies by metastatic location with substantially lower positivity rates in liver, skin and bone metastases compared with primary breast lesions or lung, soft tissue or lymph node metastases. Here, CD274 is linked to metastatic malignant neoplasm in the lymph nodes.